Healthcare provider profile · identity verified

Ryan Yarnall, MD

Internal Medicine · TULSA, OK · NPI 1861925224

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	680	199
Amlodipine Besylate	Amlodipine Besylate	245	84
Levothyroxine Sodium	Levothyroxine Sodium	222	65
Ozempic	Semaglutide	220	42
Lisinopril	Lisinopril	213	67
Omeprazole	Omeprazole	212	68
Losartan Potassium	Losartan Potassium	211	71
Duloxetine Hcl	Duloxetine Hcl	193	52
Metformin Hcl	Metformin Hcl	188	54
Gabapentin	Gabapentin	181	55
Jardiance	Empagliflozin	170	47
Fluticasone Propionate	Fluticasone Propionate	163	55
Albuterol Sulfate Hfa	Albuterol Sulfate	150	59
Pantoprazole Sodium	Pantoprazole Sodium	141	47
Rosuvastatin Calcium	Rosuvastatin Calcium	135	45
Hydrochlorothiazide	Hydrochlorothiazide	131	49
Montelukast Sodium	Montelukast Sodium	121	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	113	40
Tamsulosin Hcl	Tamsulosin Hcl	107	44
Metoprolol Succinate	Metoprolol Succinate	95	34
Metoprolol Tartrate	Metoprolol Tartrate	87	28
Carvedilol	Carvedilol	81	31
Eliquis	Apixaban	81	23
Trazodone Hcl	Trazodone Hcl	81	21
Fluoxetine Hcl	Fluoxetine Hcl	79	17
Mounjaro	Tirzepatide	72	15
Symbicort	Budesonide/Formoterol Fumarate	71	13
Pregabalin	Pregabalin	69	17
Warfarin Sodium	Warfarin Sodium	68	16
Furosemide	Furosemide	67	30
Azelastine Hcl	Azelastine Hcl	64	30
Alendronate Sodium	Alendronate Sodium	61	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	19
Allopurinol	Allopurinol	60	18
Clopidogrel	Clopidogrel Bisulfate	59	20
Potassium Chloride	Potassium Chloride	59	20
Ezetimibe	Ezetimibe	57	16
Trulicity	Dulaglutide	57	18
Metformin Hcl Er	Metformin Hcl	56	18
Sertraline Hcl	Sertraline Hcl	56	21
Spironolactone	Spironolactone	56	21
Mirtazapine	Mirtazapine	55	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	16
Hydroxyzine Hcl	Hydroxyzine Hcl	53	14
Ventolin Hfa	Albuterol Sulfate	53	18
Bupropion Xl	Bupropion Hcl	52	11
Levetiracetam	Levetiracetam	49	12
Valsartan	Valsartan	49	17
Meloxicam	Meloxicam	47	17
Ondansetron Odt	Ondansetron	46	14
Pioglitazone Hcl	Pioglitazone Hcl	46	15
Pravastatin Sodium	Pravastatin Sodium	46	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	12
Simvastatin	Simvastatin	44	13
Topiramate	Topiramate	44	15
Finasteride	Finasteride	43	14
Tizanidine Hcl	Tizanidine Hcl	42	suppressed
Baclofen	Baclofen	38	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	11
Donepezil Hcl	Donepezil Hcl	36	11
Esomeprazole Magnesium	Esomeprazole Magnesium	36	suppressed
Famotidine	Famotidine	36	11
Escitalopram Oxalate	Escitalopram Oxalate	35	suppressed
Spiriva Respimat	Tiotropium Bromide	35	suppressed
Farxiga	Dapagliflozin Propanediol	34	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	12
Lorazepam	Lorazepam	34	suppressed
Alprazolam	Alprazolam	31	suppressed
Fluconazole	Fluconazole	31	14
Chlorthalidone	Chlorthalidone	30	12
Prednisone	Prednisone	30	14
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Celecoxib	Celecoxib	29	11
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Doxepin Hcl	Doxepin Hcl	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Atenolol	Atenolol	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	17
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Vascepa	Icosapent Ethyl	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Azithromycin	Azithromycin	16	14
Lidocaine	Lidocaine	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Naltrexone Hcl	Naltrexone Hcl	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Humulin R U-500 Kwikpen	Insulin Regular, Human	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Naproxen	Naproxen	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Terazosin Hcl	Terazosin Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Lactulose	Lactulose	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Ursodiol	Ursodiol	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Methylprednisolone	Methylprednisolone	13	11
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Primidone	Primidone	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Aimovig Autoinjector	Erenumab-Aooe	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Amoxicillin	Amoxicillin	11	11
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Famotidine	Famotidine/Pf	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Ondansetron Hcl	Ondansetron Hcl/Pf	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error